CD274 and colorectal neoplasm: We evaluated the antitumor activity of the anti-PD-L1 peptides using the CT26 colorectal tumor-bearing mouse model (Fig. 6a), which has been widely used to evaluate the activity of PD-1/PD-L1 inhibitors [11, 34].